Samer Al Hadidi/UT Southwestern Simmons Cancer Center's LinkedIn
Mar 20, 2026, 16:22
Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
UT Southwestern Simmons Cancer Center shared a post on LinkedIn:
”Please join us in welcoming Samer Al Hadidi, M.D., to our blood cancers team.
He specializes in hematology and oncology, with an emphasis on plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.
Dr. Al Hadidi is the Clinical Director of the Amyloidosis Program at UT Southwestern.
He also serves as Leader of the Fellows’ Plasma Cell Disorders Clinic.
He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.
Learn more about Dr. Al Hadidi.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA